prof. MUDr. Michael Doubek, Ph.D.
vedoucí výzkumné skupiny – Výzkumná skupina Michaela Doubka: Genetické predispozice k rozvoji hematologických onemocnění
korespondenční adresa:
Jihlavská 340/20, 625 00 Brno
telefon: | 532 23 2144, 3603 |
---|---|
e‑mail: |
sociální a akademické sítě: |
---|
Počet publikací: 871
2024
-
A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study
-
Gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia
Rok: 2024, druh: Vyžádané přednášky
-
Impact of thrombocytopenia-associated c.-118C>T and c.-140C>G ANKRD26 5’UTR variants in three-generational pedigree
-
Innate effector gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia
Rok: 2024, druh: Další prezentace na konferencích
-
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients
-
Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study
-
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
-
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
HemaSphere, rok: 2024, ročník: 8, vydání: 9, DOI